— Know what they know.
Not Investment Advice

COSM NASDAQ

Cosmos Health Inc.
1W: -8.1% 1M: -26.4% 3M: -29.3% YTD: -45.1% 1Y: -34.1% 3Y: -91.8% 5Y: -95.4%
$0.28
-0.00 (-0.46%)
 
Weekly Expected Move ±9.5%
$0 $0 $0 $0 $0
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Alpha Radar Sell · Power 29 · $8.6M mcap · 21M float · 4.41% daily turnover · Short 60% of daily vol
Last Earnings 2025-11-14
EPS
$-0.17
▼ Miss -1600.0%
Revenue
$17M
▲ Beat +4.3%
Next Earnings 2026-05-20
EPS Estimate
$0.01
Range: $0.01 - $0.01
Revenue Estimate
$24M
1 analysts

Estimate vs Actual

Earnings Surprise History

5/19
EPS Beats
3/19
Revenue Beats
26%
EPS Beat Rate
16%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-05-13 quarter 2026-12-31 $-0.17 $0.06 ▲ 0.23 $31,469,887 $31,469,887
2026-05-13 quarter 2026-06-30 $-0.24 $0.01 ▲ 0.25 $23,840,824 $23,840,824
2026-04-20 quarter 2026-03-31 $-0.07 $-0.01 ▲ 0.06 $20,703,614 $21,673,476
2026-04-20 quarter 2026-06-30 $-0.03 $-0.24 ▼ 0.21 $22,773,976 $23,840,824
2026-04-20 quarter 2026-09-30 $-0.03 $0.02 ▲ 0.05 $25,051,373 $26,224,906
2026-04-20 quarter 2026-12-31 $0.02 $-0.17 ▼ 0.19 $30,061,648 $31,469,887
2026-04-20 annual 2026-12-31 $-0.11 $0.08 ▲ 0.19 $98,600,000 $103,200,000
2026-04-17 quarter 2027-12-31 $— $0.03 ▲ 0.03 $— $33,800,000
2026-04-17 quarter 2025-12-31 $— $-0.04 ▼ 0.04 $— $18,821,468
2026-04-17 quarter 2025-03-31 $— $-0.03 ▼ 0.03 $— $15,500,000
2026-04-17 quarter 2027-03-31 $— $— $— $31,100,000
2026-04-17 quarter 2026-03-31 $— $-0.07 ▼ 0.07 $— $20,703,614
2026-04-17 quarter 2024-12-31 $— $-0.09 ▼ 0.09 $— $14,500,000
2026-04-17 quarter 2026-12-31 $— $0.02 ▲ 0.02 $— $30,061,648
2026-01-16 quarter 2027-03-30 $— $— $— $31,100,000
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms